The Gram-negative selective antibiotic darobactin A has
attracted
interest owing to its intriguing fused bicyclic structure and unique
targeting of the outer membrane protein BamA. Darobactin, a ribosomally
synthesized and post-translationally modified peptide (RiPP), is produced
by a radical S-adenosyl methionine (rSAM)-dependent
enzyme (DarE) and contains one ether and one C–C cross-link.
Herein, we analyze the substrate tolerance of DarE and describe an
underlying catalytic principle of the enzyme. These efforts produced
51 enzymatically modified darobactin variants, revealing that DarE
can install the ether and C–C cross-links independently and
in different locations on the substrate. Notable variants with fused
bicyclic structures were characterized, including darobactin W3Y,
with a non-Trp residue at the twice-modified central position, and
darobactin K5F, which displays a fused diether ring pattern. While
lacking antibiotic activity, quantum mechanical modeling of darobactins
W3Y and K5F aided in the elucidation of the requisite features for
high-affinity BamA engagement. We also provide experimental evidence
for β-oxo modification, which adds support for a proposed DarE
mechanism. Based on these results, ether and C–C cross-link
formation was investigated computationally, and it was determined
that more stable and longer-lived aromatic Cβ radicals correlated
with ether formation. Further, molecular docking and transition state
structures based on high-level quantum mechanical calculations support
the different indole connectivity observed for ether (Trp-C7) and
C–C (Trp-C6) cross-links. Finally, mutational analysis and
protein structural predictions identified substrate residues that
govern engagement to DarE. Our work informs on darobactin scaffold
engineering and further unveils the underlying principles of rSAM
catalysis.